Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experience.
Herve
P
P
Bone Marrow Transplantation Unit, Hospital Jean Minjoz, Besançon, France.
Racadot
E
E
Wendling
D
D
Rumbach
L
L
Tiberghien
P
P
Cahn
J Y
JY
Flesch
M
M
Wijdenes
J
J
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000628:therapy; D001327:Autoimmune Diseases / Q000628:therapy*; D016026:Bone Marrow Transplantation; D016207:Cytokines / Q000276:immunology; D006086:Graft vs Host Disease / Q000628:therapy*; D006801:Humans; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000628:therapy; D010865:Pilot Projects; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D000911:Antibodies, Monoclonal; D016207:Cytokines; D015375:Receptors, Interleukin-2